In early 2020 we began a clinical trial to assess the efficacy of our BiotiQuest Sugar Shift Probiotic. The professionalism of the team during the pandemic resulted in a timely and cost-effective result of the highest quality. We look forward to future trials undertaken by Chauvell.
Martha Carlin, CEO, BiotiQuest, LLC
I highly recommend Chauvell to organizations seeking reliable and efficient support for GRAS dossier development and clinical trials. Their commitment to quality and efficiency makes them a standout choice in the field. We look forward to collaborating again in the future.